While 2024 focused on addressing workforce burnout, financial pressures, delayed demand, and uneven technology adoption, 2025 is positioned as a transformative year for the healthcare industry. The 43rd J.P. Morgan Healthcare Conference set a positive tone, emphasizing trends such as growing M&A opportunities, scaling AI applications across clinical and operational workflows, and renewed attention to personalized and value-based care.
Key Trends and Growth Opportunities Discussed at JP Morgan Healthcare Conference 2025
- Rising Appetite for M&A
Healthcare organizations are focusing on bolt-on acquisitions to expand service offerings and address the full care continuum. These acquisitions aim to complement existing solutions, as seen with Health Catalyst’s purchase of Upfront Healthcare Services. This addition enhances Health Catalyst’s patient engagement and analytics platform, empowering providers to improve care delivery and focus on population health.
➡️ Explore our analysis on the growth opportunities in the patient engagement market [here].
- AI Driving the Future of Healthcare
The conference showcased significant advancements in AI, underlining its potential to transform workflows and improve operational efficiencies.
- Dynamic AI Models Gaining Traction: After identification and testing phases in 2023-2024, 2025 will see these models scale up, with deeper integrations into clinical, financial, and operational systems.
- Major Investments/Funding Announced in AI Solutions:
- Qventus raised $105 million in Series D funding for its AI care orchestration platform to optimize workflows and reduce staff burden.
- Slingshot AI, developing foundational models for psychology, secured a series A funding, bringing its total capital raised to $40 million.
- Key funding milestones preceding the event: Innovaccer raised $275 million in Series F funding, Hippocratic AI secured $141 million in Series B funding, and Qualified Health received $30 million in Seed funding.
- New Product Launches:
- Waystar AltitudeAI improves denial management for providers.
- ConcertAI’s Precision360, an agentic AI solution, offers patient journey insights for near real-time clinical decision-making.
- Tempus One introduced agentic AI capabilities for managing multimodal healthcare data to improve prior authorization, patient timeline mapping, insight generation, and patient identification for clinical trials
- Talkspace Insights supports providers by automating pre- and post-session summaries, insights and documentation.
- Collaborations to Streamline AI Regulation: The Coalition for Health AI (CHAI) launched a working group to establish best practices for AI use in prior authorization workflows, aiming to unify stakeholders within six months.
- Partnerships for Accelerated AI Development:
- General Catalyst portfolio companies (e.g., Aidoc, Commure) are leveraging AWS cloud and AI solutions.
- Mayo Clinic partnered with NVIDIA to develop pathology foundation models.
➡️ Read our insights on emerging Gen AI use cases in healthcare [here].
- Workforce Well-Being Takes Center Stage
Healthcare organizations are prioritizing staff satisfaction amid shrinking labor markets and persistent burnout. Initiatives include workload streamlining, top-of-license enablement, and integration of preventive health with performance measures. For instance, Indiana University Health is addressing these concerns by adopting solutions that balance workload and provide social and financial support.
➡️ Learn how hospitals are leveraging technology to ease staff workload [here].
- Behavioral Health Innovations
The conference highlighted advancements in behavioral health solutions that enhance administrative efficiency and support the patient journey. The focus is shifting from isolated point-of-care tools to end-to-end solutions that cater to both providers and patients.
➡️ Explore our analysis of the evolving mental and behavioral health market [here].
- Spotlight on Women’s Health
The Women’s Health Series highlighted investments, policies, and innovations in this underserved sector. The Women’s Health Access Matters report urged stakeholders to prioritize areas beyond reproductive health, while companies like Organon, Hologic, and Gameto showcased progress. Additionally, Dr. Jill Biden underscored the importance of investing in women’s health research through the White House Initiative on Women’s Health Research.
➡️ Connect with our Growth Coach, Reenita Das, to discuss opportunities in women’s health [here].
- Gaps in Healthcare Financing Discussions
Noticeably absent was a deeper discussion on healthcare financing and value-based care. With political shifts and ongoing scrutiny of insurance practices, 2024 tested the resilience of this sector. The industry hopes for stabilization in 2025 under a more supportive administration, though the true impact remains to be seen.
➡️ Discover our research on the evolving value-based care environment [here].
What Lies Ahead for Healthcare in 2025
The 43rd J.P. Morgan Healthcare Conference provided a glimpse of 2025’s trajectory. With digital transformation at the forefront, opportunities abound for both established vendors and new entrants to collaborate on enhancing the healthcare industry’s physical and technological infrastructure. From regulatory advancements to AI innovations, the industry is making tangible progress in addressing workforce, policy, and care delivery challenges.
Want to Learn More?
Explore the latest trends and insights in healthcare IT by connecting with our growth experts at hello@frost.com.
